Agree a comparison with MSB and SPL pretty naive and I don’t think they know them as well as some holders (I still have some SPL). I see the opposing view on a buyback but at recent levels well below consensus it wouldn’t hurt. I agree however, as PW says it’s only a temporary measure to support the SP and he prefers to use capital elsewhere (conservatively) and makes the point of increasing Dividends to support s/holders. I wish things would have happened sooner, however, s/holders had more than one opportunity to reap large returns at $40. I think this is where PW thinks at times expectations perhaps were ahead of reality. Certainly when you compare CUV with the likes of SPL and MSB I’m pretty happy with CUV over time. GLTA
- Forums
- ASX - By Stock
- Ann: CLINUVEL Newsletter IV - October 2023
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.84%
!
$10.16

Agree a comparison with MSB and SPL pretty naive and I don’t...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.16 |
Change
-0.190(1.84%) |
Mkt cap ! $509.2M |
Open | High | Low | Value | Volume |
$10.35 | $10.44 | $10.15 | $621.4K | 60.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2039 | $10.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.17 | 124 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1094 | 10.150 |
1 | 2000 | 10.140 |
2 | 410 | 10.100 |
1 | 1000 | 10.090 |
1 | 1000 | 10.080 |
Price($) | Vol. | No. |
---|---|---|
10.170 | 124 | 1 |
10.200 | 1995 | 1 |
10.290 | 30 | 1 |
10.500 | 100 | 1 |
10.570 | 1000 | 1 |
Last trade - 16.13pm 04/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online